A breakthrough drug slows Alzheimer’s progression in major clinical trial

  • 📰 IntEngineering
  • ⏱ Reading Time:
  • 69 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Company is aiming to apply for FDA approval by March next year.

Lecanemab, a drug developed by the Japanese pharmaceutical company, Eisai Co. Ltd has shown promising results in a clinical trial by slowing cognitive decline in Alzheimer's patients who received it,. This is the first drug to blunt the progression of the symptom in the final-phase trial so far.

Tokyo-based Eisai has developed the drug with Massachusetts-based Biogen Inc. and is the second drug the collaboration has developed to lower amyloid, a toxic protein that is found in the brains of patients with Alzheimer's disease.Multiple pharmaceutical companies have attempted to develop drugs that can reduce amyloid in the brain. However, clinical trials, including one for Aduhelm, developed by Eisai and Biogen, haveThe study conducted at sites in Japan, China, Europe, and the U.S.

Participants in the study were allocated in 1:1 ratio to receive either the placebo or the drug, lecanemab. Patients in the treatment group were bi-weekly administered 10mg of each kg of body weight for a period of 18 months. When compared on a common rating scale, the drug-treated group was observed to have slowed cognitive decline in the patients by 27 percent, also compared to the placebo group, aThis is not only a significant result, but it also confirms the amyloid hypothesis for the disease progression that has come under lens after years of failed trials.Lecanemab is a monoclonal antibody that binds to neutralize and eliminate the amyloid-beta aggregates in the brain.

Prior to doing that, the full results of the study are expected to be published at a medical conference next month, following which a scientific publication is also expected,

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 287. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alzheimer's drug slows progression of cognitive decline in clinical trial, drugmakers say | CNNA monoclonal antibody treatment for Alzheimer's disease called lecanemab slows the progression of cognitive decline by 27% compared with a placebo, drugmakers Biogen and Eisai said Tuesday. Jokowi supporters brain contents That's a good one They rated a drug a placebo…? Why not another drug in the seeking or better treatment.. of course it would work ANY percentage higher above a fuckin sugar pill…
Source: cnni - 🏆 326. / 59 Read more »

Alzheimer's drug slowed progression of the disease in Phase 3 trialThe Japanese drugmaker Eisai said Tuesday its experimental drug for Alzheimer’s disease helped slow cognitive decline in patients in the early stages of the illness. I think I seen something stating viagra an other similar drugs improve blood flow to brain in Alzheimer’s Avoiding mRNA vaccine is the best.
Source: YahooNews - 🏆 380. / 59 Read more »

Alzheimer’s Drug Slows Disease Progression in TrialEisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of approval.
Source: WSJhealth - 🏆 413. / 53 Read more »

Alzheimer's-slowing drug labelled historicThe drug appears to reduce the pace of the disease, in early data from clinical trials. Don't give it to anti-vaxxers they know best.. I forgot to take mine. My dad has been diagnosed with Alzheimer since 2015, my mum found out about Sacha inchi’s oil slowing down Alzheimer, so he began to take it since 2017, just now after contracting Covid 19 ppl start to notice his illness bcos his lack of oxigent levels went down to 65% with covid
Source: bbchealth - 🏆 143. / 63 Read more »

Analysis: Alzheimer's drug trial breakthrough boost for Roche, Eli LillyThe results of a key Alzheimer's drug trial on Wednesday have reignited decades-old hopes that targeting a particular protein helps arrest the progression of the fatal brain disease, giving a big boost to similar studies being run by Roche and Eli Lilly. Earthing is good for health,effortless and cost you nothing,it's easy to DIY a grounding mat,sheet or pillow to use at home,no need to buy.🏡😷👣🌏 freemedical healthcare Inflammation antioxidant bloodcirculation Mentalhealth immunesystem insomnia Nice Is Biden taking that?
Source: Reuters - 🏆 2. / 97 Read more »